Publication Demonstrates Improved Prediction of Response to Anti-HER2 Therapy Using MammaTyper®
MammaTyper® Identified HER2-positive Patients with Greater Accuracy than Immunohistochemistry BERLIN, GERMANY, February 24, 2025 /EINPresswire.com/ -- Cerca Biotech., a Germany-based diagnostics company, announces the publication of a study …